Retinal revelations: Seeing beyond the eye with artificial intelligence

Retinal revelations: Seeing beyond the eye with artificial intelligence

Artificial intelligence (AI) has revolutionized ophthalmology by aiding in the diagnosis, prognosis, and treatment planning of various eye diseases. However, AI’s potential extends beyond ocular conditions. By analyzing eye-related biomarkers, AI can utilize the eye as a window into the body’s syste...

Full description

Saved in:

Bibliographic Details
Main Author:	John Davis Akkara
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Series:	Kerala Journal of Ophthalmology
Subjects:	age alzheimers artificial intelligence cardiovascular disease cerebrovascular disease cognitive impairment diabetes gender kidney disease liver disease machine learning oct parkinsons systemic diseases
Online Access:	https://journals.lww.com/10.4103/kjo.kjo_124_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retinal optical coherence tomography intensity spatial correlation features as new biomarkers for confirmed Alzheimer’s disease
by: Zi Jin, et al.
Published: (2025-02-01)

RETRACTED: Associations of vitamin D receptor polymorphisms with risk of Alzheimer’s disease, Parkinson’s disease, and mild cognitive impairment: a systematic review and meta-analysis
by: Yanjun Du, et al.
Published: (2024-04-01)

Role of Thyroid Hormone in Neurodegenerative Disorders of Older People
by: Arshag D. Mooradian, et al.
Published: (2025-01-01)

VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration
by: Shirel Argueti-Ostrovsky, et al.
Published: (2024-12-01)

Editorial: Oxytosis/ferroptosis: unraveling the mechanisms and its multifaceted role in neurodegenerative diseases
by: Nawab John Dar, et al.
Published: (2025-01-01)

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study
by: Chengyong Liu, et al.
Published: (2025-01-01)

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
by: Mingchun Jiang, et al.
Published: (2025-02-01)

Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium
by: Penglei Li, et al.
Published: (2024-12-01)

Cardiovascular disease essential medicines listing by countries: changes over time and association with health outcomes
by: Camila Heredia, et al.
Published: (2025-01-01)

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosisResearch in context
by: Dang Wei, et al.
Published: (2025-03-01)

Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases
by: Andrea Stoccoro
Published: (2025-01-01)

Calcium Signalling in Neurological Disorders, with Insights from Miniature Fluorescence Microscopy
by: Dechuan Sun, et al.
Published: (2024-12-01)

Modulatory effects of Lactiplantibacillus plantarum on chronic metabolic diseases
by: Lei Tian, et al.
Published: (2023-07-01)

Genetic Insights Into the Role of Cathepsins in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis: Evidence From Mendelian Randomization Study
by: Yanhong Jiang, et al.
Published: (2025-01-01)

Exploring the Link between Periodontal Disease and Systemic Conditions: Implications for Alzheimer’s, Parkinson’s, and Rheumatoid Arthritis
by: Kanimozhi, et al.
Published: (2024-12-01)

Resting-state functional magnetic resonance imaging study on cerebrovascular reactivity changes in the precuneus of Alzheimer’s disease and mild cognitive impairment patients
by: Xue Tang, et al.
Published: (2025-01-01)

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
by: Hayder M. Al-Kuraishy, et al.
Published: (2025-02-01)

Copper homeostasis and neurodegenerative diseases
by: Yuanyuan Wang, et al.
Published: (2025-11-01)

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review
by: Kisho Miyasako, et al.
Published: (2024-12-01)

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
by: Simona Denaro, et al.
Published: (2025-02-01)

Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
by: M R Essop, et al.
Published: (2023-11-01)

Retinal optical coherence tomography changes as biomarkers for Parkinsonism duration and severity in the Kashmiri population
by: Irtiqa Mohammad, et al.
Published: (2024-12-01)

Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01)

Predicting risk on cardiovascular or cerebrovascular disease based on a physical activity cohort: Results from APAC study
by: Juan Zhao, et al.
Published: (2023-04-01)

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province
by: Jia Wang, et al.
Published: (2025-01-01)

Multi-functional role of apolipoprotein E in neurodegenerative diseases
by: Sadequl Islam, et al.
Published: (2025-01-01)

Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
by: Kyoung Hwa Ha, et al.
Published: (2025-02-01)

Changing patterns of cardiovascular diseases and subtypes induced by kidney dysfunction among 25–64 years in China from 1992 to 2021
by: Guoqiang Zeng, et al.
Published: (2025-01-01)

Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
by: Yifei Cao, et al.
Published: (2025-01-01)

Body and mind: how obesity triggers neuropsychiatric and neurodegenerative disorders
by: Claudio Pirozzi, et al.
Published: (2025-01-01)

Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01)

Cognitive enhancing effect of an extract of Swertia chirata against memory impairment induced by aluminum chloride
by: Reena Deshmukh, et al.
Published: (2025-03-01)

Aging-associated sensory decline and Alzheimer’s disease
by: Suji Hong, et al.
Published: (2024-12-01)

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
by: Katharine Barnard-Kelly, et al.
Published: (2025-02-01)

Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
by: Amin Soliman, et al.
Published: (2025-01-01)

Renal Impairment Associated with Autoinflammatory Diseases
by: JIAN Shan, et al.
Published: (2024-10-01)

The Association Between Periodontitis, Gingivitis, Tooth Loss and Stroke: An Umbrella Study with Meta-Analysis
by: Jad El Masri, et al.
Published: (2024-12-01)

Compensatory increase in oxygen extraction fraction is associated with age-related cerebrovascular disease
by: John McFadden, et al.
Published: (2025-01-01)

Fighting Alzheimer’s with Movement: The Role of Physical Activity in Disease Management
by: Agnieszka Kosińska, et al.
Published: (2025-02-01)

FDG-PET-based brain network analysis: a brief review of metabolic connectivity
by: Pham Minh Tuan, et al.
Published: (2025-01-01)